Publication | Closed Access
Gender‐based evaluation of the XIENCE V™ everolimus‐eluting coronary stent system:
41
Citations
21
References
2009
Year
Women in the SPIRIT III trial had inherently higher MACE and TVF rates than men. However, the angiographic and clinical benefits of using XIENCE V stents are generalizable to women.
| Year | Citations | |
|---|---|---|
Page 1
Page 1